Any kind of stress to the body can cause an abrupt increase in glucose levels. This gives reason to define the concept of stress hyperglycaemia (SH). In general, it refers to a sudden increase in blood glucose (BG) from normal levels in connection with the acute condition. Stress hyperglycaemia is associated with adverse outcomes in various categories of acutely ill patients, and this influence is particularly pronounced in those who are not adapted to chronically high BG levels. In this regard, acute ischemic stroke is often accompanied by SH, which can have an impact on its course and outcome. Blood glucose, as a modifiable risk factor for stroke that can be therapeutically affected, demands that we know the impact of abnormal glucose levels, the consequences they are associated with, and the prognostic power they carry.
Бояджиева М. Гликемичен контрол при критично болни. Медицински университет – Варна. 2017.
Ваврек Е, Стаменова П. Исхемичен мозъчен инсулт. https://www.puls.bg/illnes/issue_169/part_10.html
Дановска М, Александрова М. Ефект на хипергликемията върху клиничния изход от спонтанен интрацеребрален кръвоизлив. Science & Technologies. Medicine. 2011;1(1):145-149.
Дановска М, Стаменов Б, Александрова М, Вълкова М. Детерминанти за повишен риск от когнитивно влошаване при остър исхемичен мозъчен инсулт. Невросонология и мозъчна хемодинамика. 2013;9(1):23-31.
Национален консенсус за профилактика, диагноза и лечение на мозъчно-съдовите заболявания. Българска неврология . 2018;19(доп.1).
Стаменова П. Исхемичен инсулт. Съвременни терапевтични стратегии в острия стадий на заболяването. MedInfo. 2016;9.
American Diabetes Association. 15. Diabetes care in the hospital: Standards of Medical Care in Diabetesd 2019. Diabetes Care. 2019;42(Suppl. 1):S173–S181.
Baird TA, Parsons MW, Phan T, et al. Persistent Poststroke Hyperglycemia Is Independently Associated With Infarct Expansion and Worse Clinical Outcome. Stroke. 2003;34(9):2208-2214.
Balintescu A, Mårtensson J. Hemoglobin A1c and Permissive Hyperglycemia in Patients in the Intensive Care Unit with Diabetes. Critical Care Clinics. 2019;35(2):289-300.
Barsheshet A, Garty M, Grossman E, et al. Admission Blood Glucose Level and Mortality Among Hospitalized Nondiabetic Patients With Heart Failure. Arch Intern Med. 2006;166(15):1613.
Burroughs V, Weinberger J. Diabetes and Stroke: Part two—Treating diabetes and stress hyperglycemia in hospitalized stroke patients. Curr Cardiol Rep. 2006;8(1):29-32.
Cerecedo-Lopez CD, Cantu-Aldana A, Patel NJ, Aziz-Sultan MA, Frerichs KU, Du R. Insulin in the Management of Acute Ischemic Stroke: A Systematic Review and Meta-Analysis. World Neurosurgery. 2020;136:e514-e534.
Chen X, Liu Z, Miao J et al. High Stress Hyperglycemia Ratio Predicts Poor Outcome after Mechanical Thrombectomy for Ischemic Stroke. J Stroke Cerebrovasc Dis. Vol. 28, No. 6 (June), 2019: pp 1668-1673.
Clement S, Braithwaite SS, Magee MF et al. Management of diabetes and hyperglycemia in hospitals. Diabetes Care. 2004; 27(2): 553–597.
Dandona P, Aljada A, Mohanty P, et al. Insulin Inhibits Intranuclear Nuclear Factor κB and Stimulates IκB in Mononuclear Cells in Obese Subjects: Evidence for an Anti-inflammatory Effect? The Journal of Clinical Endocrinology & Metabolism. 2001;86(7):3257-3265.
Di Luzio R, Dusi R, Mazzotti A, Petroni ML, Marchesini G, Bianchi G. Stress Hyperglycemia and Complications Following Traumatic Injuries in Individuals With/Without Diabetes: The Case of Orthopedic Surgery. DMSO. 2020;Volume 13:9-17.
Dungan KM, Braithwaite SS, Preiser JC. Stress hyperglycaemia. Lancet. 2009 May; 373(9677):1798–1807.
Farrokhi F, Smiley D, Umpierrez GE. Glycemic control in non-diabetic critically ill patients. Best Practice & Research Clinical Endocrinology & Metabolism. 2011;25(5):813-824.
Harada S, Fujita-Hamabe W, Tokuyama S. Ischemic Stroke and Glucose Intolerance: a Review of the Evidence and Exploration of Novel Therapeutic Targets. J Pharmacol Sci. 2012;118(1):1-13.
Hartell NA, Archer HE, Bailey CJ. Insulin-stimulated endothelial nitric oxide release is calcium independent and mediated via protein kinase B. Biochemical Pharmacology. 2005;69(5):781-790.
Hirsch IB. Sliding Scale Insulin—Time to Stop Sliding. JAMA. 2009;301(2):213.
Khalfallah M, Abdelmageed R, Elgendy E, Hafez YM. Incidence, predictors and outcomes of stress hyperglycemia in patients with ST elevation myocardial infarction undergoing primary percutaneous coronary intervention. Diabetes and Vascular Disease Research. 2020;17(1):147916411988398.
Kim J-T, Jahan R, Saver JL, for the SWIFT Investigators. Impact of Glucose on Outcomes in Patients Treated With Mechanical Thrombectomy: A Post Hoc Analysis of the Solitaire Flow Restoration With the Intention for Thrombectomy Study. Stroke. 2016;47(1):120-127.
Kim J-T, Liebeskind DS, Jahan R, et al. Impact of Hyperglycemia According to the Collateral Status on Outcomes in Mechanical Thrombectomy. Stroke. 2018;49(11):2706-2714.
Krinsley JS, Preiser J-C. Is it time to abandon glucose control in critically ill adult patients?: Current Opinion in Critical Care. 2019;25(4):299-306.
Kruyt ND, Biessels GJ, DeVries JH, Roos YB. Hyperglycemia in acute ischemic stroke: pathophysiology and clinical management. Nat Rev Neurol. 2010;6(3):145-155.
Lewis KS, Kane-Gill SL, Bobek MB, Dasta JF. Intensive Insulin Therapy for Critically III Patients. Ann Pharmacother. 2004;38(7-8):1243-1251.
Li WA, Moore-Langston S, Chakraborty T, Rafols JA, Conti AC, Ding Y. Hyperglycemia in stroke and possible treatments. Neurological Research. 2013;35(5):479-491.
Marik PE, Bellomo R. Stress hyperglycemia: an essential survival response! Published online 2013:7.
Masrur S, Cox M, Bhatt DL, et al. Association of Acute and Chronic Hyperglycemia With Acute Ischemic Stroke Outcomes Post‐Thrombolysis: Findings From Get With The Guidelines‐Stroke. JAHA. 2015;4(10).
Melamed E. Reactive hyperglycaemia in patients with acute stroke. Journal of the Neurological Sciences. 1976;29(2-4):267-275.
Mi D, Wang P, Yang B, Pu Y, Yang Z, Liu L. Correlation of hyperglycemia with mortality after acute ischemic stroke. Ther Adv Neurol Disord. 2018;11:175628561773168.
Nardi K, Milia P, Eusebi P, Paciaroni M, Caso V, Agnelli G. Predictive value of admission blood glucose level on short-term mortality in acute cerebral ischemia. Journal of Diabetes and its Complications. 2012;26(2):70-76.
Nau KC, Lorenzetti RC, Cucuzzella M, Devine T, Kline J. Glycemic Control in Hospitalized Patients Not in Intensive Care: Beyond Sliding-Scale Insulin. 2010;81(9):6.
Ntaios G, Abatzi C, Alexandrou M, et al. Persistent Hyperglycemia at 24–48 h in Acute Hyperglycemic Stroke Patients Is Not Associated with a Worse Functional Outcome. Cerebrovasc Dis. 2011;32(6):561-566.
Oddo M, Schmidt JM, Carrera E, et al. Impact of tight glycemic control on cerebral glucose metabolism after severe brain injury: A microdialysis study*: Critical Care Medicine. 2008;36(12):3233-3238.
Paciaroni M, Agnelli G, Caso V, et al. Acute Hyperglycemia and Early Hemorrhagic Transformation in Ischemic Stroke. Cerebrovasc Dis. 2009;28(2):119-123.
Parsons MW, Barber PA, Desmond PM, et al. Acute hyperglycemia adversely affects stroke outcome: A magnetic resonance imaging and spectroscopy study. Ann Neurol. 2002;52(1):20-28.
Powers WJ, Rabinstein AA, Ackerson T, et al. 2018 Guidelines for the Early Management of Patients With Acute Ischemic Stroke: A Guideline for Healthcare Professionals From the American Heart Association/American Stroke Association. Stroke. 2018;49(3).
Radermecker RP, Scheen AJ. Management of blood glucose in patients with stroke. Diabetes & Metabolism. 2010;36:S94-S99.
Rehman A, kumar A, Razzaque S, et al. Stress induced hyperglycemia in stroke patients. Pakistan Journal of Neurological Sciences (PJNS). 2015; Vol.10: Iss.2, Article 4.
Ribo M, Molina C, Montaner J, et al. Acute hyperglycemia state is associated with lower tPAinduced recanalization rates in stroke patients. Stroke. 2005;36:1705–1709.
Rosso C, Corvol J-C, Pires C, et al. Intensive Versus Subcutaneous Insulin in Patients With Hyperacute Stroke: Results From the Randomized INSULINFARCT Trial. Stroke. 2012;43(9):2343-2349.
Savopoulos C, Kaiafa G, Kanellos I, Fountouki A, Theofanidis D, Hatzitolios AI. Is management of hyperglycaemia in acute phase stroke still a dilemma? J Endocrinol Invest. 2017;40(5):457-462.
Silva-Perez LJ, Benitez-Lopez MA, Varon J, Surani S. Management of critically ill patients with diabetes. World J Diabetes. 2017;8(3):89-96.
Tomlinson D, Gardiner N. Glucose neurotoxicity. Nature Reviews Neuroscience. 2008;9:36-45.
Tziomalos K, Dimitriou P, Bouziana SD, et al. Stress hyperglycemia and acute ischemic stroke in-hospital outcome. Metabolism. 2017;67:99-105.
Wang L, Zhou Z, Tian X et al. Impact of Relative Blood Glucose Changes on Mortality Risk of Patient with Acute Ischemic Stroke and Treated with Mechanical Thrombectomy. J Stroke Cerebrovasc Dis. Vol. 28, No. 1 (January), 2019: pp 213-219.
Xing L, Liu S, Tian Y, et al. C-R Relationship between Fasting Plasma Glucose and Unfavorable Outcomes in Patients of Ischemic Stroke withoutDiabetes. Journal of Stroke and Cerebrovascular Diseases. 2019;28(5):1400-1408.
Zheng D, Zhao X. Intensive Versus Standard Glucose Control in Patients with Ischemic Stroke: A Meta-Analysis of Randomized Controlled Trials. World Neurosurgery. 2020;136:e487-e495.
